In one paragraphArticle in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Leah Rankine-WilsonDepartment of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-0049-5408 Tirosh ShapiraDepartment of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-9790-4860 Jake FelkerDepartment of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0009-0000-0617-2987 Matthew ChristoffersonDepartment of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.
Henok SahileDepartment of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Joseph ChaoDepartment of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0003-1212-7570 Houria AfsharDepartment of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.
Raymond J AndersenDepartment of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada.
Jim SunDepartment of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-6873-6052 Yossef Av-GayDepartment of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-9547-0237 Funding
Canadian Institute of Health Research 152931CIHR PJT-162424CIHR PPE-185827Cystic Fibrosis Canada AWD-021084Natural Sciences and Engineering Research Council of Canada RGPIN-2020-04032
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Mycobacterium tuberculosisVacuolar Proton-Translocating ATPasesAnimalsHumansMacrolidesMacrophagesMiceMice, Inbred C57BLMicrobial Sensitivity TestsMycobacterium abscessusMycobacterium bovisTHP-1 Cellsbafilomycin A1MacrolidesVacuolar Proton-Translocating ATPasesacidificationbafilomycinhost-directed therapyMycobacterium tuberculosisPtpAv-ATPase
Identifiers
PMID41170946
PMCPMC12691628
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390